ConductScience.org, home

Paper39551973

One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin.

Kircik L and 8 others. Int J Dermatol, 2025. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin. Papers, record 39551973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39551973

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
One Acne™: A holistic management approach to improve overall skin quality and treatment outcomes in acne with or without sensitive skin.
PubMed
Journal
Int J Dermatol
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2025-05-17
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kircik LLeon
2Tan JJerry
3Lain ETEdward Ted
4Beleznay KKatie
5Chavda RRajeevhttps://orcid.org/0000-0002-1959-1563
6Lachmann NNadège
7Brinkhuizen TTjinta
8Baldwin HHilary
9Layton AMAlison M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acne VulgarisMajor topic
Dermatologic AgentsMajor topic
CicatrixMajor topic
Holistic HealthMajor topic
Humans
Treatment Outcome
Patient Satisfaction
Hyaluronic Acid
Dermal Fillers
Retinoids
Nicotinic Acids
Skin Care

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
GaldermaPubMed

Source PubMed

Download CSV of grants

References77

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118377617Intrinsic and extrinsic factors in skin ageing: a review.Int J Cosmet Sci2008https://conductscience.org/library/papers/18377617PubMed
222007702Clinical efficacy of adapalene (differin(®)) 0.3% gel in Chilean women with cutaneous photoaging.J Dermatolog Treat2012https://conductscience.org/library/papers/22007702PubMed
338183614The Microbiome and Acne: Perspectives for Treatment.Dermatol Ther (Heidelb)2024https://conductscience.org/library/papers/38183614PubMed
414572299Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders.Am J Clin Dermatol2003https://conductscience.org/library/papers/14572299PubMed
523441236
Acne Vulgaris and the Epidermal Barrier: Is Acne Vulgaris Associated with Inherent Epidermal Abnormalities that Cause Impairment of Barrier Functions? Do Any Topical Acne Therapies Alter the Structural and/or Functional Integrity of the Epidermal Barrier?
J Clin Aesthet Dermatol2013https://conductscience.org/library/papers/23441236PubMed
614746619Inflammation in acne scarring: a comparison of the responses in lesions from patients prone and not prone to scar.Br J Dermatol2004https://conductscience.org/library/papers/14746619PubMed
724931812Neuromodulatory and anti-inflammatory ingredient for sensitive skin: in vitro assessment.Inflamm Allergy Drug Targets2014https://conductscience.org/library/papers/24931812PubMed
816048760Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments.Eur J Dermatol2005https://conductscience.org/library/papers/16048760PubMed
931524348An Advanced, Physician-Strength Retinol Peel Improves Signs of Aging and Acne Across a Range of Skin Types Including Melasma and Skin of ColorJ Drugs Dermatol2019https://conductscience.org/library/papers/31524348PubMed
1038140732Epidermal barrier function in dry, flaky and sensitive skin: A narrative review.J Eur Acad Dermatol Venereol2024https://conductscience.org/library/papers/38140732PubMed
1136361857Skin Barrier Function and the Microbiome.Int J Mol Sci2022https://conductscience.org/library/papers/36361857PubMed
1210971324Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier.Br J Dermatol2000https://conductscience.org/library/papers/10971324PubMed
1329663317Atrophic scar formation in patients with acne involves long-acting immune responses with plasma cells and alteration of sebaceous glands.Br J Dermatol2018https://conductscience.org/library/papers/29663317PubMed
1429974453Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene.Br J Dermatol2018https://conductscience.org/library/papers/29974453PubMed
1530452511Topical Tazarotene Gel, 0.1%, as a Novel Treatment Approach for Atrophic Postacne Scars: A Randomized Active-Controlled Clinical Trial.JAMA Facial Plast Surg2019https://conductscience.org/library/papers/30452511PubMed
1633671908Gelatin/Chitosan Bilayer Patches Loaded with Cortex Phellodendron amurense/Centella asiatica Extracts for Anti-Acne Application.Polymers (Basel)2021https://conductscience.org/library/papers/33671908PubMed
1729549598Adapalene 0.3% Gel Shows Efficacy for the Treatment of Atrophic Acne Scars.Dermatol Ther (Heidelb)2018https://conductscience.org/library/papers/29549598PubMed
1823467280Hyaluronic acid: A key molecule in skin aging.Dermatoendocrinol2012https://conductscience.org/library/papers/23467280PubMed
1933764577Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel.J Eur Acad Dermatol Venereol2021https://conductscience.org/library/papers/33764577PubMed
2016869175Recommendation of moisturizers and cleansers: a study of unmet needs among dermatology patients.Cutis2005https://conductscience.org/library/papers/16869175PubMed

See all 77 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42518881Efficacy and Safety Analysis of Concentrated Growth Factor Combined with Photorejuvenation for Sensitive Skin Patients: A Retrospective Cohort Study.Clin Cosmet Investig Dermatol2026https://conductscience.org/library/papers/42518881PubMed
42075875Topical Retinoids in Acne Vulgaris and Acne Scars-From Monotherapy to Combining Regimens.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075875PubMed
41949173Personalized Approach for Acne Management With Dermocosmetics According to Initial Skin Sensitivity.J Cosmet Dermatol2026https://conductscience.org/library/papers/41949173PubMed
40932054Use of Dermocosmetics in Acne Management: A Middle East-North Africa Consensus.Int J Dermatol2026https://conductscience.org/library/papers/40932054PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39551973

GET https://conductscience.org/api/papers/v1/39551973/references?page=2